Livzon Pharma Releases 2026 Interim Report; Outlines Access and Request Procedures

Bulletin Express08-21

Livzon Pharmaceutical Group Inc. (Livzon Pharma) has announced the publication of its 2026 Interim Report in both English and Chinese.

The full document can now be viewed on the company’s website (www.livzon.com.cn) and on the HKEXnews portal (www.hkexnews.hk). Shareholders are encouraged to access these digital versions.

For non-registered shareholders who experience difficulties with the online files or email notifications, printed copies are available free of charge. To obtain a hard copy of the current or any future corporate communications, recipients should complete the enclosed request form and return it to the Hong Kong branch share registrar, Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Requests may also be submitted via email to 1513-ecom@vistra.com.

Non-registered holders wishing to receive electronic communications in future must provide a functional email address to their intermediary—whether bank, broker, custodian, nominee, or HKSCC Nominees Limited. Until a valid address is supplied, notices of publication will be sent only in printed form.

Enquiries can be directed to Tricor’s hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m.-6:00 p.m. (excluding public holidays).

The notification was signed by Company Secretary Liu Ning on behalf of the board and dated 21 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1173823202?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-21 18:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173823202","market":"us","top_or_hot":-1,"title":"Livzon Pharma Releases 2026 Interim Report; Outlines Access and Request Procedures","media":"Bulletin Express","content":"<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) has announced the publication of its 2026 Interim Report in both English and Chinese.</p>\n<p>The full document can now be viewed on the company’s website (www.livzon.com.cn) and on the HKEXnews portal (www.hkexnews.hk). Shareholders are encouraged to access these digital versions.</p>\n<p>For non-registered shareholders who experience difficulties with the online files or email notifications, printed copies are available free of charge. To obtain a hard copy of the current or any future corporate communications, recipients should complete the enclosed request form and return it to the Hong Kong branch share registrar, Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Requests may also be submitted via email to 1513-ecom@vistra.com.</p>\n<p>Non-registered holders wishing to receive electronic communications in future must provide a functional email address to their intermediary—whether bank, broker, custodian, nominee, or HKSCC Nominees Limited. Until a valid address is supplied, notices of publication will be sent only in printed form.</p>\n<p>Enquiries can be directed to Tricor’s hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m.-6:00 p.m. (excluding public holidays).</p>\n<p>The notification was signed by Company Secretary Liu Ning on behalf of the board and dated 21 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Livzon Pharma Releases 2026 Interim Report; Outlines Access and Request Procedures</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLivzon Pharma Releases 2026 Interim Report; Outlines Access and Request Procedures\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-21 18:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Livzon Pharmaceutical Group Inc. (Livzon Pharma) has announced the publication of its 2026 Interim Report in both English and Chinese.</p>\n<p>The full document can now be viewed on the company’s website (www.livzon.com.cn) and on the HKEXnews portal (www.hkexnews.hk). Shareholders are encouraged to access these digital versions.</p>\n<p>For non-registered shareholders who experience difficulties with the online files or email notifications, printed copies are available free of charge. To obtain a hard copy of the current or any future corporate communications, recipients should complete the enclosed request form and return it to the Hong Kong branch share registrar, Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Requests may also be submitted via email to 1513-ecom@vistra.com.</p>\n<p>Non-registered holders wishing to receive electronic communications in future must provide a functional email address to their intermediary—whether bank, broker, custodian, nominee, or HKSCC Nominees Limited. Until a valid address is supplied, notices of publication will be sent only in printed form.</p>\n<p>Enquiries can be directed to Tricor’s hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m.-6:00 p.m. (excluding public holidays).</p>\n<p>The notification was signed by Company Secretary Liu Ning on behalf of the board and dated 21 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01513","symbol_name":"丽珠医药","start_time":0,"source_url":"","article_id":"1173823202","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173823202","pubTimestamp":1787308118,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) has announced the publication of its 2026 Interim Report in both English and Chinese. The full document can now be viewed on the company’s website...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01513":"丽珠医药"},"translate_title":"丽珠医药发布2026年中期报告；概述访问和请求程序","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01513":1},"content_text":"Livzon Pharmaceutical Group Inc. (Livzon Pharma) has announced the publication of its 2026 Interim Report in both English and Chinese.\nThe full document can now be viewed on the company’s website (www.livzon.com.cn) and on the HKEXnews portal (www.hkexnews.hk). Shareholders are encouraged to access these digital versions.\nFor non-registered shareholders who experience difficulties with the online files or email notifications, printed copies are available free of charge. To obtain a hard copy of the current or any future corporate communications, recipients should complete the enclosed request form and return it to the Hong Kong branch share registrar, Tricor Investor Services Limited, 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Requests may also be submitted via email to 1513-ecom@vistra.com.\nNon-registered holders wishing to receive electronic communications in future must provide a functional email address to their intermediary—whether bank, broker, custodian, nominee, or HKSCC Nominees Limited. Until a valid address is supplied, notices of publication will be sent only in printed form.\nEnquiries can be directed to Tricor’s hotline at (852) 2980 1333, Monday to Friday, 9:00 a.m.-6:00 p.m. (excluding public holidays).\nThe notification was signed by Company Secretary Liu Ning on behalf of the board and dated 21 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1173823202","isCrawlerRequest":true}